{"title":"GlaxoSmithKline v. Teva: Federal circuit broadens induced infringement to preclude marketing generics for off-patent indications","authors":"Paul A. Braier","doi":"10.1177/1741134321999698","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15914,"journal":{"name":"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector","volume":"20 1","pages":"97 - 101"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1741134321999698","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
